Cover Image
市場調查報告書

遠端患者監護系統的全球市場

Remote Patient Monitoring Systems

出版商 Global Industry Analysts, Inc. 商品編碼 339777
出版日期 內容資訊 英文 273 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
遠端患者監護系統的全球市場 Remote Patient Monitoring Systems
出版日期: 2015年07月01日 內容資訊: 英文 273 Pages
簡介

本報告提供遠端患者監護系統的全球市場,提供您美國,加拿大,日本,歐洲,亞太地區,南美,及其他地區等各個地區之個別分析,從2014年到2020年各年的實際成果/推估及預測,再彙整主要83家企業及利基企業公司簡介。

第1章 簡介,調查方法,產品定義

  • 調查的可靠性和報告的限制
  • 免責聲明
  • 資料的解釋和報告作成層級
    • 定量技術及分析法
  • 產品的定義和調查範圍

第2章 摘要整理

  • 產業概要
    • 遠端患者監護 (RPM) :醫療提供的變革模式
    • 對患者,醫生及費用負擔者而言的恩惠
    • 提高患者的治療結果和推動自我護理
    • 資源的最佳化節減:主要的恩惠
    • 費用負擔者的恩惠
    • 主要的推動市場成長要素的概況
    • 在全球性醫療費上升中,醫療經濟的關注度大增
    • 高齡人口產生高度需求
    • 慢性疾病管理顯示出巨大的市場機會
    • 對醫院的再住院懲罰條例提供了轉換到RPM的契機
    • 穿戴式設備促進RPM的引進
    • 創業投資家積極對RPM技術企業提供資金
    • 市場上問題與課題
    • 遠端患者監護系統的高成本
    • 缺乏給付
    • 患者的隱私相關疑慮
    • 小規模的診療所受到遠程監控計劃的挑戰
    • 醫療設備的安全性問題
    • 競爭情形
  • 市場趨勢/課題
    • 巨量資料的管理對有效RPM而言相當重要
    • 物聯網 (IoT) :對醫療而言重要
    • 雲端運算:強化RPM的引進
    • 夥伴關係活用互相的專門技術
    • 行動醫療是否會造成傳統RPM陳腐化?
    • 無線消費者設備比遠程醫療較受喜愛
    • 不能動的患者有利於遠程監控設備的引進增加
    • CVD依然在遠程監控中持續熱門
    • 遠程監控:對CIED患者而言的治療新標準
    • RPM削減了糖尿病管理相關成本
    • 神經退化性疾病症狀的遠程監控
    • EEG及治療合理的遠程監控
    • 對慢性阻塞性肺病及氣喘的管理而言重要的遠程監控
    • 遠隔血壓監測的重要性擴大有利於市場上引進
    • 睡眠呼吸中止症的遠端患者監護
  • 產品概要
    • 簡介
    • 遠端患者監護 VS 遠程醫療
    • 目前監控系統:系統評估
    • 遠端患者監護:架構
    • 遠程監控系統的優點與課題
  • 產品的發表/認證
  • 產業的最新趨勢
  • 主要的國際企業
  • 全球市場的展望

第3章 市場

  • 美國
  • 加拿大
  • 日本
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 中國
    • 其他亞太地區
  • 南美
    • 巴西
    • 其他南美國家
  • 其他地區

第4章 競爭情形

目錄
Product Code: MCP-7076

This report analyzes the worldwide markets for Remote Patient Monitoring Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 83 companies including many key and niche players such as -

Abbott Laboratories
Aerotel Medical Systems
AMD Global Telemedicine, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Remote Patient Monitoring (RPM) - A Transformation Model for Health Care Delivery
  • Benefits for Patients, Physicians, & Payer
  • Improved Patient Outcomes and Promoting Self-Care
  • Resource Optimization and Savings - A Key Benefit
  • Payer Benefits
  • Peek into Key Market Growth Drivers
  • Focus on Healthcare Economics Grows as Healthcare Expenditures Rise Globally
    • Table 1: Global Healthcare Spending (in US$ Trillion): 2013-2018 (includes corresponding Graph/Chart)
    • Table 2: Healthcare Expenditure as a % of GDP Across Select Countries (includes corresponding Graph/Chart)
    • Table 3: Elderly Healthcare Expenditure as a % of GDP (includes corresponding Graph/Chart)
  • Aging Population Creates High Demand
    • Table 4: Ageing (65+) Demographics as % of Total Population by Country (2000, 2011, 2020) (includes corresponding Graph/Chart)
  • Chronic Disease Management Presents Huge Market Opportunity
    • Table 5: World Market for Telehealth: Patient Distribution (in %) by Disease Condition (includes corresponding Graph/Chart)
    • Table 6: Chronic Disease Management in Developed Countries (2014): Percentage Distribution of Patient Population by Chronic Disease Type in the US, Germany, and the UK (includes corresponding Graph/Chart)
  • Readmission Penalty on Hospitals Provides Impetus to RPM
    • Patient Non-Adherence to Prescribed Medication Promotes RPM Market
    • Table 7: Medication Adherence Rates in the US by Condition (2012) (includes corresponding Graph/Chart)
  • Wearable Devices Help Boost RPM Adoption
  • Venture Capitalists Keen to Fund RPM Technology Companies
    • Table 8: Digital Health Venture Funding in the US (2011-2014) (includes corresponding Graph/Chart)
    • Table 9: US Digital Health Venture Capital Funding by Category (in %): 2014 (includes corresponding Graph/Chart)
  • Market Issues and Challenges
  • High Cost of Remote Patient Monitoring Systems
  • Lack of Reimbursement
  • Patient Privacy Concerns
  • Small Practices Challenged by Remote Monitoring Programs
  • Security Issues of Medical Devices
  • Competitor Landscape
    • Table 10: Leading Players in the Global Remote Patient Monitoring Market: Percentage Breakdown of Market Share for Boston Scientific, GE Healthcare, Medtronic, Philips Healthcare, St. Jude Medical, and Others (includes corresponding Graph/Chart)

2. MARKET TRENDS/ISSUES

  • Big Data Management Crucial for Effective RPM
  • Internet of Things (IoT) - Crucial for Healthcare
  • Cloud Computing: Enhancing RPM Adoption
  • Partnerships Leverage on Mutual Expertise
  • Will mHealth make Conventional RPM Obsolete?
  • Wireless Consumer Devices Favored Over Telehealth
  • Immobile Patients to Gain from Increased Uptake of Remote Monitoring Devices
  • CVD Continues to Grab Focus for Remote Monitoring
    • Table 11: Global Annual Medical Cost of CVD in US$ Billion (2010-2030) (includes corresponding Graph/Chart)
    • Table 12: Economic Burden of Cardiovascular Diseases between 2011 and 2015: Breakdown of Lost Output Value by Income Group (includes corresponding Graph/Chart)
  • Remote Monitoring - New Standard of Care for Patients with CIEDs
  • RPM to Reduce Costs Associated with Diabetes Management
    • Table 13: Global Diabetes Mellitus Incidence among Ages 20-79 (2014E & 2035P): Prevalence (in Millions) and Percentage Share by Geographic Region (includes corresponding Graph/Chart)
    • Table 14: Top Ten Countries Worldwide with the Highest Number of People (in the Age Group 20-79 Years) with DM (in Millions): 2014E & 2035P (includes corresponding Graph/Chart)
  • Remote Monitoring for Neurodegenerative Disease Conditions
  • Remote Monitoring of EEG & Treatment Adequacy
  • Remote Monitoring Crucial for COPD and Asthma Management
  • Rising Significance of Remote Blood Pressure Monitoring Benefits Market Adoption
    • Table 15: Death Rates Due to Hypertension in Select Countries: 2012 (includes corresponding Graph/Chart)
    • Table 16: Percentage Prevalence Rate of High Blood Pressure for Patients over 25 Years of Age by Region (1980 and 2013) - Africa, America, South East Asia, Europe, Eastern Mediterranean, and Western Pacific (includes corresponding Graph/Chart)
  • Remote Patient Monitoring for Sleep Apnea
    • Table 17: Percentage Prevalence of Sleep Apnea in Co-Morbidities by Type of Co-Morbidity (includes corresponding Graph/Chart)

3. PRODUCT OVERVIEW

  • Introduction
  • Remote Patient Monitoring vs. Telehealth
  • Current Monitoring Systems - A Systematic Review
  • Remote Patient Monitoring - Architecture
  • Benefits & Challenges of Remote Patient Monitoring Systems

4. PRODUCT LAUNCHES/APPROVALS

  • Omron Healthcare Launches BP Monitor
  • ALR Technologies Seeks FDA Approval for New Health-e-Connect Feature
  • HTC Launches Monitoring Device HTC Grip
  • Covidien Receives CE Marking for Nellcor System
  • Intel-GE Launches Branded Health Harmony RPM Service
  • Dexcom Receives FDA Approval for Dexcom SHARE Device
  • Honeywell Unveils New Version of Genesis DM™
  • Honeywell Unveils Latest Version of LifeStream™
  • AMD Introduces Live Streaming Ultrasound Technology
  • Vital Connect Receives FDA Clearance for HealthPatch™ Biosensor
  • OSTAR Healthcare Launches Remote Patient Monitoring System in North America
  • Masimo's Radius-7 Wearable Monitor Receives CE Approval
  • CardioMEMS System Receives FDA Approval
  • ReliantHeart's Assist5® Ventricular Assist Device Receives CE Certification
  • HealthInterlink Receives 510(k) clearance for Beacon version 2.0
  • Verizon Receives FDA Clearance for Patient Engagement Tool
  • Sensiotec Unveils Version 2.0 of Virtual Medical Assistant®
  • InfoBionic Receives CE Certification for MoMe™ System
  • Baxter Receives CE Marking for VIVIA Hemodialysis System
  • Verizon Launches Remote Patient Monitoring Platform
  • Preventice Receives CE Certification for BodyGuardian® Monitoring System
  • Sorin's Smartview System Receives FDA Approval
  • Healthx Launches Remote Patient Monitoring Platform
  • Tactio Health Group Launches TactioDiabetes
  • FDA Approves RP-VITA By iRobot Corp. & InTouch Health

5. RECENT INDUSTRY ACTIVITY

  • Integrity Applications Enters Distribution Agreements with Chinese Players
  • Roche and Qualcomm Enter Collaboration
  • Honeywell Life Care and MobileHelp Expand Collaboration
  • Honeywell HomMed Changes Name to Honeywell Life Care
  • Welch Allyn Acquires HealthInterLink
  • LabCorp and Envision Healthcare Invest in Vivify Health
  • Vital Connect Enters Partnership with LifeWatch
  • Aerocrine Collaborates with Microsoft
  • Preventice and eCardio Diagnostics Enter Strategic Partnership
  • Geneia Acquires Select Rights on ZephyrLIFE From Covidien
  • Healthsense Raises Funding for Remote Patient Monitoring System
  • Maxis Bhd and EWL Announce Partnership for Health Monitoring M2M Solution
  • eCardio Signs Agreement with Shandong Yocaly
  • Medtronic Acquires Cardiocom
  • CardioNet Enters Agreement with IMEC & Holst Centre

6. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories (US)
  • Aerotel Medical Systems (Israel)
  • AMD Global Telemedicine, Inc. (US)
  • BIOTRONIK SE & Co. KG (Germany)
  • Boston Scientific Corporation (US)
  • GE Healthcare Ltd. (UK)
  • Honeywell Life Care Solutions (US)
  • Intelesens Ltd. (UK)
  • LifeWatch AG (Switzerland)
  • Masimo Corporation (US)
  • Medtronic Plc (Ireland)
  • Mindray North America (US)
  • Nihon Kohden Corporation (Japan)
  • Omron Healthcare, Inc. (US)
  • Philips Healthcare (Netherlands)
  • Qualcomm Life, Inc. (US)
  • St. Jude Medical Inc. (US)
  • Welch Allyn, Inc. (US)

7. GLOBAL MARKET PERSPECTIVE

    • Table 18: World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for Remote Patient Monitoring Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Key Drivers to Remote Patient Monitoring Market
    • Remote Monitoring Boosted by HRRP
    • High Life Expectancy Presents Strong Need for RPM
    • Table 21: Population of the US (2010, 2030 & 2050): Percentage Breakdown by Age Groups - Under 18, 18-64 years & 65+ years (includes corresponding Graph/Chart)
    • US - The Leading Market for Remote Cardiac Monitoring
    • Table 22: CVD in the US: Cardiovascular Disease Prevalence in Adults by Gender & Age Group (includes corresponding Graph/Chart)
    • Table 23: CVD in the US: Cardiovascular Disease Incidence by Gender & Age Group (per 1,000 Adults) (includes corresponding Graph/Chart)
    • Table 24: Leading Causes of CVD Fatalities in the US: Percentage Breakdown of Mortality for Coronary Heart Disease, HBP, Heart Failure, Stroke, and Others (includes corresponding Graph/Chart)
    • Chronic Disease Management - Focus Area for Remote Monitoring
    • Table 25: US Healthcare Spending (2006-2020) (in US$ Trillion) (includes corresponding Graph/Chart)
    • Table 26: US Healthcare Market: Total Annual Expenditure in US$ Billion by Chronic Disorder/Disease (includes corresponding Graph/Chart)
    • Diabetes Statistics in the US
    • Table 27: Prevalence of Diabetes Mellitus in the US (2013 & 2035): Number of People with DM (in Thousands) in the 20-79 Age Group
    • Sleep Apnea in the US
    • Rise in COPD Incidence Drives RPM Adoption
    • Table 28: Chronic Obstructive Pulmonary Disorder (COPD) Incidence in US (2014): COPD Prevalence in Millions by Age Group (includes corresponding Graph/Chart)
    • Reimbursement Scenario
    • Remote Monitoring Systems with FDA 510(k) Clearance (2014):
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 29: US Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 30: US Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Product Launch
  • B. Market Analytics
    • Table 31: Canadian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 32: Canadian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Graying Population Spurs Growth of Patient Monitoring Equipment
    • Table 33: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
    • Key Player - Nihon Kohden Corporation
  • B. Market Analytics
    • Table 34: Japanese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 35: Japanese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Prevalence of Diabetes in Europe: Market Opportunity for CGM Devices
  • B. Market Analytics
    • Table 36: European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: European Historic Review for Remote Patient Monitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 38: European 14-Year Perspective for Remote Patient Monitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 39: French Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: French Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Key Player - Biotronik SE & Co. KG
  • B. Market Analytics
    • Table 41: German Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 42: German Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Product Launch
  • B. Market Analytics
    • Table 43: Italian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 44: Italian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Telecare and Elderly Population Requirements - An Overview
    • Self-Monitoring Blood Glucose Meters Gain Popularity
    • Product Approval
    • Key Players
  • B. Market Analytics
    • Table 45: UK Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 46: UK Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 47: Spanish Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 48: Spanish Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 49: Russian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 50: Russian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 51: Rest of European Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 52: Rest of European Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • Improving Infrastructure Facilitates RPM Adoption
    • Undiagnosed Diabetic Population Offers Potential for Remote Monitoring
  • B. Market Analytics
    • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 54: Asia-Pacific Historic Review for Remote Patient Monitoring Systems by Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 55: Asia-Pacific 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for China and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5a. CHINA

  • A. Market Analysis
    • Large Population Results in Quicker RPM Adoption
    • Table 56: Healthcare Expenditure in China as a % of GDP (2006-2015) (includes corresponding Graph/Chart)
    • Table 57: Percentage of Population Aged 65 and Above in China (2000-2020) (includes corresponding Graph/Chart)
    • Table 58: Incidence of Chronic Diseases in China (2014) (includes corresponding Graph/Chart)
    • China: An Untapped Goldmine for Blood Glucose Monitoring Devices
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 59: Chinese Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 60: Chinese Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

5b. REST OF ASIA-PACIFIC

  • A. Market Analysis
    • India: Remote Patient Monitoring Gains Popularity
    • Rising Diabetic Populace Spurs Growth in Remote Glucose Monitoring Devices
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 61: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 62: Rest of Asia-Pacific Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 63: Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 64: Latin American Historic Review for Remote Patient Monitoring Systems by Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 65: Latin American 14-Year Perspective for Remote Patient Monitoring Systems by Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6a. BRAZIL

  • Market Analysis
    • Table 66: Brazilian Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 67: Brazilian Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

6b. REST OF LATIN AMERICA

  • Market Analysis
    • Table 68: Rest of Latin American Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 69: Rest of Latin American Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Key Player - Aerotel Medical Systems (Israel)
  • B. Market Analytics
    • Table 70: Rest of World Recent Past, Current & Future Analysis for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 71: Rest of World Historic Review for Remote Patient Monitoring Systems Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2013 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top